Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Interest & Investment Income came in at $793000.0 in Q1 2026, up 24.88% year-on-year from $635000.0 in Q1 2025, and up 137.14% quarter-over-quarter from -$2.1 million in Q4 2025.
Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 24.88% year-over-year to $793000.0 in Q1 2026; TTM through Mar 2026 was -$526000.0, a 132.01% decrease from a year earlier, with the FY2025 full-year figure at -$28000.0, down 100.59% from the prior year.
- Interest & Investment Income advanced to $793000.0 in Q1 2026 per TNYA's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.8 million in Q2 2023 and bottomed at -$2.1 million in Q4 2025.
- The 5-year median for Interest & Investment Income is $143000.0 (2024), against an average of $150823.5.
- Across the five-year window, Interest & Investment Income tumbled 877.97% in 2022 and soared 4635.71% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at -$1.2 million in 2022, then surged by 113.43% to $155000.0 in 2023, then jumped by 423.87% to $812000.0 in 2024, then slumped by 362.93% to -$2.1 million in 2025, then jumped by 137.14% to $793000.0 in 2026.
- Per Business Quant, the three latest TNYA Interest & Investment Income figures stand at $793000.0 (Q1 2026), -$2.1 million (Q4 2025), and $1000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Tenaya Therapeutics | 166.70 Mn | 166.70 Mn | - | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | -2.14 Mn |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 635,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -28,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | -118,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 9,000.00 |